Search

everythinglearnresearchcommunity

for

Search:↓

Androgens reduce BMP2, which weakens the ability of certain cells to help hair stem cells become different types of cells.

Glioblastoma cells can make androgens, which might help the tumor grow.

The mouse models are effective for testing new hair loss treatments.

Eplerenone, a mineralocorticoid receptor antagonist, was found to promote hair growth in human hair follicles.

Blocking glucocorticoid receptors improves glucose metabolism in a PCOS mouse model.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

AKR1C3 could be a treatment target for metabolic issues in PCOS.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

Found key genes affecting hair loss, immune response, and skin development; more research needed for better treatments.

A new mutation in the human glucocorticoid receptor reduces its function and causes resistance to glucocorticoids.

Prolactin affects hair growth cycles and can cause early hair follicle regression.

The mineralocorticoid receptor may play a role in skin and hair health and could be a new target for treating related disorders.

The study concluded that testing hormone levels after stimulation is not reliable for identifying carriers of 21-hydroxylase deficiency; genetic testing is necessary.

A substance called Vascular Endothelial Growth Factor can protect certain hair follicle stem cells from damage caused by androgens, suggesting a new possible treatment for hair loss.

Certain gene variations might help protect against insulin resistance and glucose intolerance in people with Polycystic Ovary Syndrome.

A certain gene variation is linked to a higher risk of polycystic ovarian syndrome in South Indian women.

Male pattern hair loss could hint at androgens affecting COVID-19 severity.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Human skin cells contain Protease Nexin-1, and male hormones can decrease its levels, potentially affecting hair growth.

Male hormones indirectly affect skin cell development by increasing growth factor levels from skin fibroblasts.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

A new gene mutation may allow some piebaldism patients to regain skin color in white patches.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

Flutamide and finasteride reduced sex hormones in pregnant hyenas, but increased them in males.

The study created a new method to test drugs that affect hormone processing in skin.

Finasteride helps treat skin issues like acne and baldness by blocking testosterone conversion.

Females have higher estrogen receptor levels in hair than males, and these levels decrease in white hair compared to black hair.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

Women with myotonic dystrophy might get diseases related to male hormones because their body tissues are extra sensitive to these hormones.